Andere talen Amphastar Pharmaceuticals, Inc.

Aandelen

AMPH

US03209R1032

Geschatte realtime Cboe BZX Andere beurzen 19:57:26 10-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
41,17 ^USD	+1,13%		-2,60%	-33,47%

04/06	Amphastar Pharmaceuticals, Inc. Keurt de benoeming van Howard Lee als bestuurder goed	CI
22/05	Sectorupdate: Gezondheidszorgaandelen licht hoger aan het eind van de middag	MT

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Amphastar Pharmaceuticals, Inc. Approves the Appointment of Howard Lee as Director	04/06
Amphastar Pharmaceuticals' Board Approves $50 Million Increase to Share Buyback Plan	04/06
Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol	23/05
Sector Update: Health Care Stocks Slightly Higher Late Afternoon	22/05
Sector Update: Health Care Stocks Advance Wednesday Afternoon	22/05
Amphastar Pharmaceuticals Gains US FDA Approval for Generic Bronchospasm Drug	22/05
Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol	22/05
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024	09/05
Amphastar: Q1 Earnings Snapshot	08/05
Amphastar Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
Earnings Flash (AMPH) AMPHASTAR PHARMACEUTICALS Reports Q1 EPS $1.04, vs. Street Est of $0.79	08/05
Earnings Flash (AMPH) AMPHASTAR PHARMACEUTICALS Reports Q1 Revenue $171.8M, vs. Street Est of $174.7M	08/05
HINTERGRUND/FTC knöpft sich Patentanmeldungen für Arzneimittel vor	01/05
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	30/04
Top Midday Stories: Shares of Eli Lilly, HSBC Get Post-Earnings Bump; BBVA Exploring Merger With Sabadell; FTC Disputes 300 'Junk' Patent Listings	30/04
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	30/04
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	30/04
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	30/04
Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference	02/04
Amphastar Pharmaceuticals Insider Sold Shares Worth $842,883, According to a Recent SEC Filing	08/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Amphastar Pharmaceuticals, Inc.

Aandelen

AMPH

US03209R1032

Andere talen

Filters